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Abstract
Background: The Crigler-Najjar syndrome is extremely rare genetic disease, that is
manifested by severe jaundicedue to lack of UDP glucuronosyltransferase 1-A1 (UDP)
activity. The main treatment is to use the blue lightphototherapy, during the prolong
time, during the day every day.
Methods: Here, we analyzed human UDP’s correlation with the blue light
phototherapy using the nonlinear physico-mathematical model: Resonant
Recognition Model (RRM), which proposes that protein activation is electromagnetic
in nature within the frequency range of infrared and visible light.
Results: We found that human UDP’s are characterized by specific RRM frequency
that is related to the blue light radiation. This could be the explicit explanation, why
phototherapy with the blue light could replace lack of UDP activity.
Conclusion: However, the blue light treatment is less effective with ageing, due to
decrease of the blue lightpenetration through skin. Thus, there is a need for
alternative treatments. Here, we propose to design de-novopeptide, using this
specific RRM frequency. Such peptide, according to RRM, is proposed to have the
samebiological function as UDP glucuronosyltransferase 1-A1 and thus can be used
for alternative treatment of Crigler-Najjar syndrome.
Keywords: Crigler-Najjar syndrome, Resonant Recognition Model, Phototherapy,
Bioactive peptide design, Macromolecular interaction
Background
The Crigler-Najjar syndrome is extremely rare genetic disease affecting the metabo-
lisms of bilirubin, resulting in a form of non-hemolytic jaundice [1]. This disease is
caused by lack of expression of UDP glucuronosyltransferase 1-A1. Hence, there is no
response to treatment with phenobarbital. The only available treatment is photother-
apy, which involves radiation of patients with the blue light for an extensive time every
day, usually whole night. Similar treatment is used for jaundice in new born babies.
However, the blue light treatment is fully effective only with babies and youngsters, as
with older people the blue light skin penetration is decreasing. Thus, there is a need
for alternative treatments for Crigler-Najjar syndrome.
Here, we have investigated: how and why, the specific blue light radiation can mimic
activity of UDP glucuronosyltransferase 1-A1. For that purpose, we used Resonant
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Recognition Model (RRM) [2–4], which is nonlinear physico-mathematical model,
proposing that protein activities and interactions are electromagnetic in nature and
are at the specific frequency for each biological function [2–6]. We found that spe-
cific RRM frequency for UDP glucuronosyltransferase 1-A1biological function is
within the blue light frequency range. This finding explicitly explains, why the blue
light can mimic and replace activity of UDP glucuronosyltransferase 1-A1. In
addition, using this specific frequency, we designed de-novo peptide that is, accord-
ing to RRM [2–4], proposed to have the same biological function as UDP glucurono-




The RRM postulates that protein interactions entail a mechanism of resonant energy
transfer between involved molecules at the frequency specific for each observed
function/interaction [2–4]. This proposal is based on the findings that certain peri-
odicities within the distribution of energy of delocalized electrons along a protein
molecule are critical for protein biological function and/or interaction with their
targets [2–4]. If charge transfer through these macromolecules is introduced, then
charge moving through macromolecular backbone can produce electromagnetic
radiation, absorption and resonance with spectral characteristics corresponding to
the energy distribution [2–6].
The RRM has been well explained in our earlier publications [7] with the
following:
“The RRM enables the calculation of these spectral characteristics, by assigning
each amino acid a physical parameter representing the energy of delocalized elec-
trons of each amino acid. Comparing Fourier spectra for this energy distributions by
using cross-spectral function, it has been found that proteins sharing the same bio-
logical function/interaction share the same periodicity (frequency) within energy dis-
tribution along the macromolecule [2–4]. Furthermore, it has been shown that
interacting proteins and their targets share the same characteristic frequency, but
have opposite phase at characteristic frequency [2–4, 8]. Thus, it has been proposed
that the RRM frequencies characterize, not only a general function, but also a recog-
nition and interaction between the particular macromolecule and its target, which
then can be considered to be resonant recognition. This could be achieved with res-
onant energy transfer between the interacting macromolecules through oscillations
of a physical field, which is electromagnetic in nature. Since there is evidence that
proteins and DNA have certain conducting or semi-conducting properties, a charge
moving through the macromolecular backbone and passing different energy stages,
caused by different amino acid or nucleotide side groups, can produce sufficient con-
ditions for a specific electromagnetic radiation or absorption. The frequency ranges
of this field depend on the charge velocity. The RRM proposes that the charge is
travelling through the macromolecular backbone at the estimated velocity of
7.87x105m/s [2, 3]. For this velocity and with the distance between amino acids in a
protein molecule of 3.8 Å, the frequency of protein interactions was estimated to be
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in the range between 1013Hz and 1015Hz. Therefore, the estimated frequency range
for both amino acid and nucleotide macromolecules includes infra-red, visible and
ultra-violet light. To support this idea, we compared our computational predictions
with a number of published experimental results [2–4, 8]:
 Laser light growth promotion of cells, by using the particular frequencies of light to
produce the similar effect to that of growth factor proteins;
 Chymotrypsin activation (increase of enzyme activity) achieved by laser light
radiation in a range of 850–860 nm;
 Activation of highly homologous plant photoreceptors which, although being very
homologous, absorb different wavelengths of light;
 Photo activated proteins, e.g. rhodopsin, flavodoxin, etc.
These comparisons have shown a strong linear correlation between frequencies, as
calculated using the RRM method and experimentally measured characteristic frequen-
cies, with the slope factor of K = 201 [2–4, 8]. This finding parallels with the frequency
range previously associated with the RRM numerical frequency spectrum that has been
calculated from the charge velocities through the protein backbone. This correlation
can be represented as following:
λ ¼ K=frrm
where λ is the wavelength of light irradiation in nm, which can influence a particular
biological process, frrm is a RRM numerical frequency and K is coefficient of this linear
correlation.
We applied this concept on a number of proteins and DNA examples. The con-
cept has been also experimentally tested by predicting the electromagnetic frequen-
cies for L-Lactate Dehydrogenase [5], where by radiating L-Lactate Dehydrogenase
with predicted calculated electromagnetic frequencies the significant change in
enzyme activity was achieved. The concept has also been tested independently on
experimental measurements of photon emission from dying melanoma cells [9], on
photon emission from lethal and non-lethal Ebola strains [10], as well as on classic
signaling pathway, JAK-STAT, traditionally composed of nine sequential protein
interactions [11].
Keeping all this in mind, we propose that the RRM concept is excellent predictor for
proteins and DNA selective interactions, biological processes and pathways in living
cells” [7].
In addition, once the characteristic frequency for biological function of the protein
has been identified, it is possible to design new proteins/peptides with these desired
frequency components and consequently with this desired biological function. Such
approach has been already successfully applied and experimentally tested in design
of FGF analogue [2–4, 12], HIV envelope protein analogue [2–4, 13] and peptide to
mimic myxoma virus oncolytic function [14, 15].
Sequences
In our study we used six HUMAN UDP-glucuronosyltransferase proteins and
bilirubin-inducible fluorescent protein UnaG, that binds unconjugated bilirubin with
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high affinity. All of these protein sequences have been collected from UNIPROT data-
base, as listed below:
o P22309|UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS = Homo sapiens
GN =UGT1A1 PE = 1 SV = 1
o P35503|UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS = Homo sapiens
GN =UGT1A3 PE = 1 SV = 1
o P22310|UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS = Homo sapiens
GN =UGT1A4 PE = 1 SV = 1
o P35504|UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS = Homo sapiens
GN =UGT1A5 PE = 2 SV = 1
o P19224|UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS = Homo sapiens
GN =UGT1A6 PE = 1 SV = 2
o O60656|UD19_HUMAN UDP-glucuronosyltransferase 1-9 OS =Homo sapiens
GN =UGT1A9 PE = 1 SV = 1
o P0DM59|UNAG_ANGJA Bilirubin-inducible fluorescent protein UnaG
OS = Anguilla japonica PE = 1 SV = 1.
Results and Discussion
We have analyzed six HUMAN UDP-glucuronosyltransferase proteins using the RRM
and it has been revealed that the common frequency for all analyzed sequences is at
frequency of f = 0.3799 ± 0.0072, as presented in Fig. 1.
To make sure that this frequency is related to UDP function in bilirubin metabol-
ism, we have also compared these six human UDP’s with beta-barrel protein (angja),
that binds bilirubin with high affinity. The result is the more prominent peak at
frequency of f = 0.3799 ± 0.0072, as presented in Fig. 2. This confirms that frequency
of f = 0.3799 ± 0.0072 is common to UDP’s and angja proteins.
Thus, we can propose that this characteristic frequency is critical for metabolism of
bilirubin. According to RRM this numerical frequency is related to electromagnetic
radiation range between 519 and 539 nm, calculated as per formula above and encompass
with the blue light spectrum, as presented in Fig. 3.
Fig. 1 Spectrum for six human UDP proteins showing prominent common peak at frequency of
f = 0.3799 ± 0.0072
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Here, we found using the RRM, that characteristic frequency for human UDP’s func-
tion in bilirubin metabolism is encompassing the blue light radiation. This is crucial
finding, that could be the explicit explanation, why phototherapy with the blue light
could replace lack of UDP activity. It is for the first time that the RRM could be used
in calculating the characteristic frequencies of phototherapy for specific treatments.
The blue light phototherapy for the Crigler-Najjar syndrome is less effective in grownup
patients, as the blue light penetration through the skin is diminishing with ageing of the
patient. Thus, there is a need for alternative approach to treatment of Crigler-Najjar
syndrome. We propose to utilize the RRM approach to design peptides that would have
only the established characteristic frequency related to bilirubin metabolism. Such peptide
potentially can have UDP activity and thus can be used in treatment of Crigler-Najjar
syndrome.
Using the RRM we have designed the 20 amino acids sequence that has only frequency
of f = 0.3799 and phase same as within UD11_HUMAN UDP-glucuronosyltransferase
protein sequence. The designed sequence is: RLDYHDECTNDKADLRQEDP.
Fig. 2 Spectrum for six human UDP proteins together with angja protein showing single prominent peak
at frequency of f = 0.3799 ± 0.0072
Fig. 3 The electromagnetic spectrum (photo from web page: astronomersgroup.org)
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We propose that this designed peptide could be used in treatment of Crigler-Najjar
syndrome.
Conclusion
The lack of activity of UDP proteins in Crigler-Najjar syndrome is replaced by the blue light
phototherapy treatment. Here for the first time, we found the biophysical relationship be-
tween activity of UDP proteins and the blue light using the nonlinear physico-mathematical
model: Resonant Recognition Model (RRM), which proposes that protein activation is
electromagnetic in nature within the frequency range of infrared and visible light. We found
that human UDP’s are characterized by specific RRM frequency that is related to the blue
light. This could be the explicit explanation, why phototherapy with the blue light could
replace lack of UDP activity.
However, the blue light treatment is fully effective only with babies and youngsters,
as with older people the blue light skin penetration is decreasing. Thus, using this
specific RRM frequency, we designed de-novo peptide that is, according to RRM,
proposed to have the same biological function as UDP glucuronosyltransferase 1-A1.
Such peptide can be used for treatment of Crigler-Najjar syndrome.
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